# GPT-5.2 Review

**Role:** External referee review
**Model:** openai/gpt-5.2
**Paper:** paper.pdf
**Timestamp:** 2026-02-26T17:04:46.345159
**Route:** OpenRouter + LaTeX
**Review mode:** Tri-model (3 independent reviewers)
**Tokens:** 15997 in / 4604 out
**Response SHA256:** 6863765f37a39fad

---

## Summary and main take

The paper asks whether Brexit propagated to French housing markets through pre-existing UK–France social/migration networks. Empirically, it uses (i) a continuous-treatment DiD interacting a département-level UK exposure measure with a post-2016Q2 indicator (Eq. (1)), and (ii) a triple-difference exploiting house vs apartment heterogeneity with département×quarter fixed effects (Eq. (2)). The central scientific claim is a *UK-specific demand channel* (distinct from generic “cosmopolitan” trends), with the German exposure serving as a placebo.

The paper is thoughtful and unusually candid about identification failures (German placebo in baseline DiD; sensitivity to trends; low precision in the triple-diff). However, as written it does **not yet meet top-journal publication readiness** because (a) the causal estimand is not clearly defined relative to multiple post-2016 shocks (Brexit vs Covid vs general globalization), (b) key identifying assumptions for the triple-difference are asserted but not convincingly validated, (c) inference choices need to be strengthened for a 96-unit panel with strong common shocks and many specifications, and (d) the strongest “significant” results are precisely those most vulnerable to differential trends (event-study pretrends borderline; coefficient disappears with trends).

Below I focus on scientific substance, identification, inference, and what must change for a credible causal interpretation.

---

# 1. Identification and empirical design (critical)

### 1.1 What is the treatment and what is the causal estimand?
- The design treats **Brexit (post-2016Q3)** as the common shock and **UK connectedness/UK stock** as cross-sectional exposure intensity (Sections 1, 3).
- But Brexit is not a single shock: referendum (2016), Article 50 (2017), transition and final exit (2020–2021), plus exchange-rate movements and uncertainty. The paper uses a single Post dummy “from 2016-Q3 onward” (Eq. (1)), which implicitly defines an estimand akin to an *average post-2016 differential trend*, not a referendum-specific or exchange-rate-specific effect.

**Why it matters:** Without a sharper estimand, it is too easy for any post-2016 divergence correlated with international exposure (and later Covid-era rural dynamics, which you explicitly flag in Discussion) to be attributed to “Brexit through networks.”

**Concrete fix:** Define primary estimand(s) precisely. For example:
1) “Referendum shock” effect: 2016Q3–2017Q4 window only;  
2) “Brexit era” effect: 2016Q3–2019Q4;  
3) “Full sample” as descriptive.  
Then commit ex ante to which is the main causal claim.

### 1.2 Baseline continuous-treatment DiD: parallel trends looks weak
- You report event-study pretrend joint tests: **p = 0.038 (SCI) and p = 0.048 (stock)** (Results, “Event Studies”). That is *evidence against* the identifying assumption for Eq. (1).
- Adding département-specific linear trends eliminates the stock effect (Table 1 col. 6; Table 4 col. 6): the coefficient is essentially zero.

**Interpretation:** The baseline DiD appears to be picking up differential trends correlated with UK stock (or the same “international openness” factor highlighted by the German placebo). In a top-journal setting, you cannot treat the baseline DiD as supportive causal evidence with these diagnostics.

**Concrete fix:** Reframe Eq. (1) results as *non-causal / suggestive descriptive patterns*, and move causal emphasis to designs that pass pretrend and placebo tests.

### 1.3 Post-treatment measurement of SCI (2021) remains an issue
- You acknowledge SCI is measured in 2021 (Introduction; Data; Identification). You attempt to address this by using pre-determined census stocks and by residualizing SCI.

**But:** residualizing SCI is not a solution to post-treatment measurement; and using the 2016 stock shifts the exposure concept from “social networks” to “migration stocks.” That is fine, but then the paper’s headline “social networks” mechanism becomes less directly identified.

**Concrete fix:** Clarify the role of SCI:
- Either (A) treat SCI mainly as a proxy and the main exposure as the pre-2016 stock; or  
- (B) use a pre-period SCI if available (Meta has earlier SCI vintages for some releases) or show stability of SCI rankings over time (e.g., correlate 2021 SCI with any earlier network proxy; at minimum show it is strongly predicted by *pre-2014* stocks if available).

### 1.4 German placebo: good diagnostic, but it undermines baseline and complicates interpretation
- Baseline DiD German exposure effect is larger than UK (Table 1 col. 5), which strongly suggests cosmopolitan confounding.
- Triple-diff German placebo is null (Table 2 col. 4), which you interpret as a success.

**Concern:** The German placebo only works if Germans truly should not generate house-vs-apartment differential responses *and* if other shocks correlated with German connectedness would affect both property types symmetrically. That symmetry assumption is not established.

**Concrete fix:** Add additional placebo exposures/countries and demonstrate the pattern is truly UK-specific:
- E.g., Netherlands/Belgium (geographic proximity), Spain/Italy (second homes), US (cosmopolitan), Switzerland (you already compute SCI(CH)). A top-journal audience will want to see that the UK is an outlier in the triple-diff, not one of many noisy positives/zeros.

### 1.5 Triple-difference identification: promising but still not fully credible as written
Eq. (2) with département×quarter FE is strong: it absorbs any département-quarter shocks common to both types. Identification is then from **within-départment-quarter house vs apartment differential** varying with exposure after 2016.

Key required assumption: **Absent UK-specific demand, the house–apartment gap would evolve similarly across exposure levels** (Section 3.3; “Pre-Trend Validation for the Triple-Difference”).

You provide:
- A gap event-study pretrend test with **p = 0.240 for the census stock** (good). But you don’t report the analogous statistic for SCI gap, and the figure note suggests multiple panels; in text you highlight only stock.
- You also note that the “full triple event study” cannot include département×quarter FE (Figure 3 notes), meaning the displayed dynamic pattern is not for the main identifying specification.

**Big unresolved threat (your own Discussion): Covid-era rural house boom correlated with UK-connected areas.**
- You explicitly state triple-diff on pre-Covid 2014–2019 gives coefficient ≈ 0, p = 0.972 (Discussion). That is potentially fatal to a Brexit interpretation. It suggests the house-vs-apartment differential emerges in 2020–2023 (remote work / rural amenities), not 2016–2019.

**Concrete fix:** This must be front-and-center and addressed with design, not just caveated.
- Make *pre-Covid* the primary causal window for Brexit (e.g., through 2019Q4).  
- Alternatively, implement a **two-shock design**: separate PostBrexit (2016Q3–2019Q4) and PostCovid (2020Q1+) with interactions Exposure×House×PostBrexit and Exposure×House×PostCovid. If the “Brexit” coefficient is ~0 and “Covid” is positive, then the paper is not about Brexit.

### 1.6 Composition and quality of transacted properties
- Outcome is median price per m² in département-quarter and by type (Data). You discuss compositional concerns (Section 3 “Threats”).

**Remaining concern:** Even within type, composition can shift (size, location within département, age/quality). Median price per m² can change if, for example, Brexit or Covid changed which houses transacted (more rural communes; different size distribution).

**Concrete fix:** In DVF microdata you likely observe surface area and possibly rooms/lot proxies. Consider:
- A hedonic or reweighted price index within département×type×quarter (or commune-level) to hold composition fixed; or  
- At minimum, show that **average/median surface area and other observables** do not shift differentially by exposure after 2016 for houses relative to apartments (a “composition placebo” in the triple-diff spirit).

---

# 2. Inference and statistical validity (critical)

### 2.1 Standard errors and clustering
- You cluster at département level throughout (tables’ notes). With 96 clusters, asymptotics are plausible, but the setting has:
  - strong common time shocks (national housing cycle),
  - serial correlation,
  - many specifications/event-study coefficients.

**Concerns:**
- For Eq. (1), two-way clustering (département and quarter) is mentioned in text (Robustness) but not systematically reported for main tables.
- For Eq. (2), with département×quarter FE and only 96 clusters, inference can be delicate because the regressor varies only across départements (Exposure) interacted with Post×House; residual correlation might not be well captured by one-way clustering.

**Concrete fix (must for top journals):**
- Report **wild cluster bootstrap p-values** (e.g., Webb weights) for key coefficients, especially the triple-diff UK and German placebo coefficients, and for event-study pretrend tests.
- Report two-way clustering as a robustness table (not just a sentence), or justify why one-way is conservative/appropriate.

### 2.2 Multiple testing / specification search risk
You run multiple exposure measures (SCI, stock, residualized), multiple samples (full, no IdF, no Corsica, 2014–2018, binary quintile), plus multiple outcomes (overall, triple diff). The narrative picks “wins” and “fails” honestly, but formal inference is not adjusted.

**Concrete fix:**
- Pre-specify a *primary* specification and a small number of confirmatory tests (UK triple-diff + German placebo triple-diff as a joint test).  
- Consider a simple family-wise adjustment (Holm) for a defined family (e.g., the five triple-diff columns) or report sharpened q-values.

### 2.3 Event-study implementation details need tightening
- You report joint F-tests of pre-coefficients (good), but not:
  - exact pre-period window,
  - whether event-time coefficients are normalized properly when treatment is continuous and time-invariant,
  - whether you include leads/lags symmetrically and how you handle sparse early quarters (you mention missing cells).

**Concrete fix:** Provide explicit event-study equation(s) and show:
- number of leads/lags,
- omitted period,
- weights (if any),
- whether you use balanced panel or not, and whether missingness correlates with exposure.

### 2.4 Randomization inference
- You permute census stock across départements 2,000 times (Robustness). This is a good addition, but it is not clear whether:
  - FE structure is re-estimated in each permutation (you imply yes),
  - the permutation respects spatial correlation or regional structure,
  - the RI p-value is computed as two-sided.

**Concrete fix:** Clarify and strengthen:
- Report RI p-values in table form for the main baseline and triple-diff specifications.
- Consider **restricted randomization** (e.g., within broader regions / NUTS1 / macro-regions) to avoid implausible permutations if exposure is spatially clustered.

---

# 3. Robustness and alternative explanations

### 3.1 Covid and remote work are a first-order alternative explanation
You already note the triple-diff seems driven by 2020–2023 (Discussion). This is not a footnote; it is the dominant alternative mechanism.

**Concrete fix:** Explicitly estimate and report:
- Brexit-era effect (2016Q3–2019Q4),
- Covid-era effect (2020Q1–2023Q4),
within the same regression framework, with the triple-diff FE structure. This will directly adjudicate the competing explanation.

### 3.2 Mechanisms: exchange rate interaction is not UK-specific (German placebo significant)
Table 5 shows sterling weakness × DE exposure is significant and larger. This undermines the exchange-rate mechanism as identified.

**Concrete fix:**
- Treat the exchange-rate interaction as descriptive only unless you can isolate plausibly exogenous sterling movements unrelated to broader EU macro conditions (hard).
- Alternatively, test a **UK-specific uncertainty measure** (e.g., UK Economic Policy Uncertainty index or Brexit-related news intensity) interacted with exposure, with a German placebo. If that is also not UK-specific, mechanisms remain speculative.

### 3.3 Residualization as “orthogonalization” is not causal and may induce bias
You correctly flag residualization as descriptive (Discussion), but earlier (Introduction) it is pitched as an “identification innovation.” Residualization can also exacerbate measurement error and change estimands.

**Concrete fix:** Reposition residualization as a *diagnostic* and do not treat insignificance as evidence of confounding without additional structure (e.g., a partial identification argument or sensitivity analysis).

### 3.4 Spatial spillovers and nearby substitution
You mention spillovers likely bias toward zero (Section 3 threats), but do not test.

**Concrete fix:** Add:
- distance-to-UK / ferry/air connections controls,
- spatial lags or exclude neighbors of top-exposure départements as robustness,
- or show results are similar when aggregating to larger regions to reduce spillover contamination.

---

# 4. Contribution and literature positioning

### 4.1 Contribution is clearer methodologically than substantively
The methodological message—SCI-based exposure designs can be “cosmopolitan confounded,” and placebos + within-unit triple-diff can help—is valuable.

But for top general-interest journals, the paper needs a clearer “so what” on Brexit/housing *or* a stronger general methodological theorem/guide. As written, the substantive Brexit conclusion is “suggestive, modest, imprecise” (Discussion/Conclusion), which may not clear the bar unless the methodological innovation is made more general and decisive.

**Concrete fix:** Either:
- (A) Recast as a methods-and-application paper: present a general framework/diagnostic protocol for SCI exposures, with Brexit as a case study; or
- (B) Strengthen the substantive causal result by isolating the Brexit window and ruling out Covid.

### 4.2 Missing / useful references to consider
On DiD with continuous intensity and exposure/shift-share:
- Borusyak, Hull, Jaravel (2022) you cite; also consider explicit *continuous treatment DiD* discussions and diagnostics (e.g., recent applied guidance in JEP/AEJ Applied contexts).
On foreign housing demand and price indices:
- Work on composition-adjusted house price indices and transaction composition (Case-Shiller style ideas; Eurostat/OECD methods). Even if not directly cited, showing awareness matters.
On Brexit spillovers:
- There is work on Brexit uncertainty and local exposure; if not already, include canonical Brexit uncertainty papers and local exposure measures beyond the ones cited, to position novelty.

(You already cite many relevant papers; the bigger issue is aligning the contribution with what the design can actually identify.)

---

# 5. Results interpretation and claim calibration

### 5.1 Over-claiming risks
- Abstract/Introduction language (“exogenous shock transmitted,” “isolates UK-specific demand”) is stronger than what the evidence supports given:
  - baseline pretrend failures,
  - attenuation with trends,
  - triple-diff imprecision and apparent Covid dependence.

**Concrete fix:** Calibrate the headline claim: “Brexit-era” vs “post-2016 era,” and explicitly separate “diagnostic results about SCI confounding” from “evidence of Brexit affecting French housing.”

### 5.2 Magnitudes and economic significance
- Table 1 col (2): 0.0106 on log stock × Post implies ~1.1% differential in prices per log point of stock. That might be small/moderate, but the paper should translate it into:
  - effect comparing, say, 25th vs 75th percentile exposure,
  - and cumulative euros/m² in representative départements.

This is not style; it is substantive interpretation needed for a policy journal audience.

### 5.3 Internal consistency
- The paper says the triple-diff is the centerpiece and “cleanest evidence,” but also admits it vanishes pre-Covid. That contradiction needs resolution: either it is a Brexit paper (then show effect pre-Covid) or it is a paper about how network-exposed places experienced *later* shifts (then “Brexit” in title/abstract is misleading).

---

# 6. Actionable revision requests (prioritized)

## 1) Must-fix issues before acceptance

1. **Separate Brexit from Covid in the core estimand and main regressions.**  
   - *Why:* Your own evidence suggests the triple-diff signal is driven by 2020–2023, undermining a Brexit interpretation.  
   - *Fix:* Redefine post indicators (PostBrexit 2016Q3–2019Q4; PostCovid 2020Q1+) and estimate both interactions (Exposure×House×PostBrexit and Exposure×House×PostCovid) in the triple-diff FE structure. Make the Brexit-window result the main claim if it exists; otherwise, change title/framing.

2. **Strengthen inference for the triple-diff and key DiD estimates.**  
   - *Why:* With 96 clusters and heavy FE saturation, conventional clustered SEs may misstate uncertainty; and the main triple-diff results are marginal.  
   - *Fix:* Report wild cluster bootstrap p-values (and/or randomization inference p-values) for the UK triple-diff and German placebo triple-diff. Add two-way clustering robustness systematically.

3. **Make the baseline DiD explicitly non-causal unless pretrends are fixed.**  
   - *Why:* Pretrend tests reject at ~5% and trends kill the effect.  
   - *Fix:* Move Eq. (1) to motivating/descriptive; or rework design (short window, flexible trends, or matched trends) so that a causal interpretation is defensible.

4. **Validate the triple-diff identifying assumption beyond one gap pretrend test.**  
   - *Why:* The key assumption is type-symmetric confounding within département-quarter; this can fail with differential composition and differential exposure to macro shocks by type.  
   - *Fix:* Add composition checks (surface area, transaction mix) and placebo outcomes (e.g., log transactions by type; if UK demand falls, quantities should respond). Show that pre-2016 dynamics of the house–apartment gap do not vary with exposure for both SCI and stock.

## 2) High-value improvements

5. **Expand placebo set beyond Germany.**  
   - *Why:* A single placebo can be special. The claim is “UK-specific.”  
   - *Fix:* Run triple-diff placebos for several countries and show UK is uniquely positive (or among a theoretically predicted set), with a clear rationale.

6. **Clarify the role of SCI vs census stock in the causal story.**  
   - *Why:* SCI is post-treatment; stock is pre-treatment but not “social networks.”  
   - *Fix:* Either shift the narrative to migration-stock exposure as main, or provide stronger evidence that SCI reflects stable pre-existing network structure (ranking stability; correlation with older measures).

7. **Improve mapping from estimates to economic magnitudes.**  
   - *Why:* Needed to assess substantive importance and policy relevance.  
   - *Fix:* Report interquartile effects and implied €/m² impacts; discuss whether magnitudes are plausible given UK buyer shares.

## 3) Optional polish (still substantive-adjacent)

8. **Address missing département-quarter cells and weighting.**  
   - *Why:* Missingness may correlate with rurality/exposure and can bias medians.  
   - *Fix:* Show robustness to weighting by transaction counts; show results on a balanced panel subset.

9. **Consider a more structural “demand shock” proxy.**  
   - *Why:* Without nationality of buyers, inference is indirect.  
   - *Fix:* Use quantities (transactions) and days-on-market proxies if available; test whether high-exposure areas show demand-side adjustments consistent with price effects.

---

# 7. Overall assessment

### Key strengths
- Excellent diagnostic mindset: you confront the German placebo and pretrend issues rather than hiding them (Introduction; Discussion).
- The triple-difference with département×quarter FE is a conceptually strong strategy to remove many confounders (Section 3.3).
- Data are rich (universe DVF transactions) and the topic is broadly interesting.

### Critical weaknesses
- The “Brexit” causal interpretation is not currently credible because the most credible design (triple-diff) appears driven by Covid-era dynamics, while the baseline DiD fails pretrends and is not robust to trends.
- Inference needs upgrading (bootstrap/RI reporting, clustering choices) given marginal significance and many specifications.
- Mechanism evidence (exchange rate) fails a key placebo, so mechanism claims should be dialed back or redesigned.

### Publishability after revision
A strong **major revision** could yield a publishable paper, but only if the authors (i) cleanly separate Brexit from Covid and (ii) deliver a credible, well-powered UK-specific result in the pre-Covid Brexit window *or* reframe the paper away from Brexit toward a broader methodological contribution with an application showing how misleading naive SCI designs can be.

DECISION: MAJOR REVISION